Decanoylcarnitine Inhibits Triple-Negative Breast Cancer Progression via Mmp9 in an Intermittent Fasting Obesity Mouse

Conclusion: This study pioneers the exploration of IF intervention and the role of decanoylcarnitine/Mmp9 in the progression of TNBC in obese mice, enhancing our comprehension of the potential roles of various dietary patterns in the process of cancer treatment.PMID:38409962 | DOI:10.1177/15330338241233443

Source: Technology in Cancer Research and Treatment - February 27, 2024 Category: Cancer & Oncology Authors: Yifan Tang Shuai Chen Saijun Wang Ke Xu Kun Zhang Dongmei Wang Ninghan Feng Source Type: research